Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 40

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 40
---
 may not be able to continue operating as a going concern.                                                                                                                                          |
| ● | The fertility market in which NewGenIvf participates is competitive, and if NewGenIvf does not continue to compete effectively, its results of operations could be materially and adversely affected. |
| ● | NewGenIvf has a limited operating history with its current platform of solutions, which makes it difficult to predict its future prospects, financial performance and results of operations.          |
| ● | Our planned Solana strategy may not be successful                                                                                                                                                     
 and exposes us to various risks, including risks associated with the Solana network, SOL token and the blockchain sector.                                                                             |

| ● | NewGenIvf’s marketing efforts depend significantly on its ability to receive positive references from its existing clients.                                                            |
| ● | If NewGenIvf is unable to attract new clients, its business, financial condition and results of operations would be adversely affected.                                                |
| ● | NewGenIvf’s business depends on its ability to maintain its existing client demographics. Any failure to do so would harm its business, financial condition and results of operations. |

| ● | If NewGenIvf fails to offer high-quality support, its reputation could suffer.                                                                                                                                       |
| ● | NewGenIvf’s failure to effectively develop and expand its marketing and sales capabilities could harm its ability to increase its client base and achieve broader market acceptance of solutions NewGenIvf provides. |
| ● | NewGenIvf may experience net losses and may not sustain profitability in the future.                                                                                                                                 |

<div align='center'>21</div>

| ● | NewGenIvf’s future revenue may not grow at the rates it historically has, or at all.                                                                                                                  |
| ● | NewGenIvf’s quarterly and annual results may fluctuate significantly and may not fully reflect the underlying performance of NewGenIvf’s business.                                                    |
| ● | If the estimates and assumptions NewGenIvf uses to determine the size of the target markets for its services are inaccurate, its future growth rate may be impacted and its business would be harmed. |
| ● | NewGenIvf may not be able to successfully manage its growth, and if NewGenIvf is not able to grow efficiently, its business, financial condition and results of operations could be harmed.           |

| ● | If NewGenIvf’s new solutions and services are not adopted by its clients, or if it fails to innovate and develop new offerings that are adopted by its clients, its revenue and